Thanks bloblu, true to your word as always. If they "go it alone" in this world of dead end big pharma projects that would not be a good sign. June conference, hmmm, if data were that good an expedited journal submission would seem the way to go rather than wait these six months more (that is a one year delay from originally forecast data presentation), my take is that they are not on fire. bp
Market Data 
Markets 
AI
